The FDA has even authorised a drug designed with cannabidiol for that purpose (Epidiolex). Though the company only suggests it for 2 scarce forms of childhood epilepsy identified as Lennox-Gastaut syndrome and Dravet syndrome.Employing these solutions at a younger age particularly improves the probability of producing a cannabis use condition later